{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:07:22Z","timestamp":1778641642087,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":20,"publisher":"Springer New York","isbn-type":[{"value":"9781461432081","type":"print"},{"value":"9781461432098","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-1-4614-3209-8_93","type":"book-chapter","created":{"date-parts":[[2014,3,24]],"date-time":"2014-03-24T07:46:47Z","timestamp":1395647207000},"page":"741-747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Therapy Strategies for Usher Syndrome Type 1C in the Retina"],"prefix":"10.1007","author":[{"given":"Kerstin","family":"Nagel-Wolfrum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timor","family":"Baasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Wolfrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"93_CR1","first-page":"51","volume-title":"Usher syndrome: pathogenesis, diagnosis and therapy","author":"U Wolfrum","year":"2011","unstructured":"Wolfrum U (2011) Protein networks related to the Usher syndrome gain insights in the molecular basis of the disease. In: Satpal A (ed) Usher syndrome: pathogenesis, diagnosis and therapy. Nova Science Publishers, USA, pp\u00a051\u201373"},{"key":"93_CR2","first-page":"377","volume-title":"Usher syndrome: pathogenesis, diagnosis and therapy","author":"N Overlack","year":"2011","unstructured":"Overlack N, Goldmann T, Wolfrum U, Nagel-Wolfrum K (2011) Current therapeutic strategies for human Usher syndrome. In: Ahuja S (ed) Usher syndrome: pathogenesis, diagnosis and therapy. Nova Science Publishers, Inc. USA, pp\u00a0377\u2013395"},{"key":"93_CR3","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1172\/JCI42258","volume":"120","author":"AI den Hollander","year":"2010","unstructured":"den Hollander AI, Black A, Bennett J, Cremers FP (2010) Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies. J Clin Invest 120:3042\u20133053","journal-title":"J Clin Invest"},{"key":"93_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1167\/iovs.10-5620","volume":"52","author":"K Nagel-Wolfrum","year":"2011","unstructured":"Nagel-Wolfrum K, Becker M, Goldmann T, Muller C, Vetter J, Wolfrum U (2011) USH1C Transcripts and harmonin protein expression in human retina. Invest Ophthalmol Vis Sci 52:45","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"93_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/156652311794520120","volume":"11","author":"EM H\u00e4ndel","year":"2011","unstructured":"H\u00e4ndel EM, Cathomen T (2011) Zinc-finger nuclease based genome surgery: it\u2019s all about specificity. Curr Gene Ther 11:28\u201337","journal-title":"Curr Gene Ther"},{"key":"93_CR6","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1167\/iovs.12-9812","volume":"53","author":"N Overlack","year":"2012","unstructured":"Overlack N, Goldmann T, Wolfrum U, Nagel-Wolfrum K (2012) Gene repair of an Usher syndrome causing mutation by zinc-finger nuclease mediated homologous recombination. Invest Ophthalmol Vis Sci 53:4140\u20134146","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"93_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1534\/genetics.110.120717","volume":"186","author":"M Christian","year":"2010","unstructured":"Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, Bogdanove AJ, Voytas DF (2010) Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186:757\u2013761","journal-title":"Genetics"},{"key":"93_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/wrna.95","volume":"2","author":"KM Keeling","year":"2011","unstructured":"Keeling KM, Bedwell DM (2011) Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases. Wiley Interdiscip Rev RNA 2:837\u2013852","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"93_CR9","doi-asserted-by":"publisher","first-page":"6310","DOI":"10.1016\/j.bmcl.2006.09.013","volume":"16","author":"I Nudelman","year":"2006","unstructured":"Nudelman I, Rebibo-Sabbah A, Shallom-Shezifi D, Hainrichson M, Stahl I, Ben Yosef T, Baasov T (2006) Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations. Bioorg Med Chem Lett 16:6310\u20136315","journal-title":"Bioorg Med Chem Lett"},{"key":"93_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00439-007-0410-7","volume":"122","author":"A Rebibo-Sabbah","year":"2007","unstructured":"Rebibo-Sabbah A, Nudelman I, Ahmed ZM, Baasov T, Ben Yosef T (2007) In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome. Hum Genet 122:373\u2013381","journal-title":"Hum Genet"},{"key":"93_CR11","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.1167\/iovs.10-5741","volume":"51","author":"T Goldmann","year":"2010","unstructured":"Goldmann T, Rebibo-Sabbah A, Overlack N, Nudelman I, Belakhov V, Baasov T et al (2010) Beneficial read-through of a USH1C nonsense mutation by designed aminoglycoside NB30 in the retina. Invest Ophth Vis Sci 51:6671\u20136680","journal-title":"Invest Ophth Vis Sci"},{"key":"93_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1039\/b712690p","volume":"6","author":"M Hainrichson","year":"2008","unstructured":"Hainrichson M, Nudelman I, Baasov T (2008) Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases. Org Biomol Chem 6:227\u2013239","journal-title":"Org Biomol Chem"},{"key":"93_CR13","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1021\/jm801640k","volume":"52","author":"I Nudelman","year":"2009","unstructured":"Nudelman I, Rebibo-Sabbah A, Cherniavsky M, Belakhov V, Hainrichson M, Chen F et al (2009) Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations. J Med Chem 52:2836\u20132845","journal-title":"J Med Chem"},{"key":"93_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/hum.2010.067","volume":"22","author":"T Goldmann","year":"2011","unstructured":"Goldmann T, Overlack N, Wolfrum U, Nagel-Wolfrum K (2011) PTC124-Mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C. Hum Gene Ther 22:537\u2013547","journal-title":"Hum Gene Ther"},{"key":"93_CR15","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/emmm.201201438","volume":"4","author":"T Goldmann","year":"2012","unstructured":"Goldmann T, Overlack N, Moller F, Belakhov V, van Wyk M, Baasov T et al (2012) A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation. Embo Mol Med 4:1186\u20131199","journal-title":"Embo Mol Med"},{"key":"93_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-med-120611-144851","volume":"64","author":"SW Peltz","year":"2012","unstructured":"Peltz SW, Morsy M, Welch EM, Jacobson A (2012) Ataluren as an agent for therapeutic nonsense suppression. Annu Rev Med 64:407\u2013425","journal-title":"Annu Rev Med"},{"key":"93_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ki.2010.337","volume":"79","author":"JM Lopez-Novoa","year":"2011","unstructured":"Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ (2011) New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 79:33\u201345","journal-title":"Kidney Int"},{"key":"93_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/MOO.0b013e32833e05ec","volume":"18","author":"ME Warchol","year":"2010","unstructured":"Warchol ME (2010) Cellular mechanisms of aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg 18:454\u2013458","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"93_CR19","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s00109-011-0787-6","volume":"89","author":"SM Rowe","year":"2011","unstructured":"Rowe SM, Sloane P, Tang LP, Backer K, Mazur M, Buckley-Lanier J, Nudelman I, Belakhov V, Bebok Z, Schwiebert E et al (2011) Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54. J Mol Med 89:1140\u20131161","journal-title":"J Mol Med"},{"key":"93_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ymgme.2011.10.005","volume":"105","author":"D Wang","year":"2012","unstructured":"Wang D, Belakhov V, Kandasamy J, Baasov T, Li SC, Li YT, Bedwell DM, Keeling KM (2012) The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse. Mol Genet Metab 105:116\u2013125","journal-title":"Mol Genet Metab"}],"container-title":["Advances in Experimental Medicine and Biology","Retinal Degenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-3209-8_93","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:22:03Z","timestamp":1676384523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4614-3209-8_93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9781461432081","9781461432098"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-3209-8_93","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"25 March 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}